ArticleBiomedicines2025

SMYD3-CDCP1 Axis Drives EMT and CAF Activation in Colorectal Cancer and Is Targetable for Oxaliplatin Sensitization.

Liming Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.